About
Incontinence Implant
Areas of Focus
Categories
Medical ImplantMidwest
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
656
By Phase
NA: 4
By Status
RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT04248283Lead Sponsor
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
NARecruiting
167 participants
Started: Jan 26, 2021 · Completed: Dec 30, 2025
NCT03767595Lead Sponsor
ProACT Post-Approval Study
NARecruiting
145 participants
Started: Feb 19, 2019 · Completed: Sep 1, 2030
NCT00277095Lead Sponsor
ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males
NACompleted
123 participants
Started: Aug 31, 2005 · Completed: Dec 31, 2017
NCT00113555Lead Sponsor
Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence
NACompleted
221 participants
Started: Dec 31, 2001 · Completed: Nov 30, 2010
Locations (1)
Headquarters
Plymouth, MN, United States
Map
Loading map...